NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Cingulate Inc. Common Stock Share Price Chart

O H L

Cingulate Inc. Common Stock Performance Overview

Days Range
$5.13Low
$5.20High

Markets Today

Previous Close$5.15
Open$5.13
Volume19,442
Day's Range$5.13 - $5.20
52W Range$3.16 - $11.89
Market Cap$74.02 M

Historical Performance

1M Returns-0.96
3M Returns+3.21
6M Returns-35.95
1Y Returns+46.31
5Y ReturnsNA
10Y ReturnsNA

Cingulate Inc. Common Stock Fundamentals

Market Cap$74.02 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-4.51
EPS TTM$-3.68
Quarterly Earnings Growth YOYN/A
PB Ratio3.01
EBITDA$-19.40 M
Profit MarginN/A
Market Cap$74.02 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-4.51
EPS TTM$-3.68
Quarterly Earnings Growth YOYN/A
PB Ratio3.01
EBITDA$-19.40 M
Profit MarginN/A

Cingulate Inc. Common Stock Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$0$0$0$0$0$0
Gross Profit +$0$0$0$0$0$0
Operating Income -$3.71 M-$4.65 M-$6.00 M-$5.59 M-$7.92 M-$5.41 M
EBITDA -$3.54 M-$4.50 M-$5.89 M-$5.46 M-$7.80 M-$5.32 M
Interest Expense -$96.66 K-$138.76 K$0$0-$536.84 K-$141.28 K
Depreciation $165.29 K$146.99 K$106.78 K$121.83 K$121.19 K$98.24 K
Income Before Tax -$3.85 M-$4.98 M-$7.34 M-$6.27 M-$9.31 M-$5.87 M
Income Tax Expense $0$0$0$0$0$0
Net Income +-$3.85 M-$4.98 M-$7.34 M-$6.27 M-$9.31 M-$5.87 M
Net Profit Margin ------

Cingulate Inc. Common Stock Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $382$488$596$725$1.19 K$1.39 K
Reserve & Surplus -$112.29 M-$117.08 M-$126.10 M-$132.38 M-$141.69 M-$147.56 M
Non-Current Liabilities $923.70 K$1.22 M$1.16 M$2.25 M$1.04 M$968.46 K
Current Liabilities $5.62 M$6.73 M$5.88 M$10.31 M$10.96 M$8.63 M
Total Liabilities $6.54 M$7.96 M$7.05 M$12.56 M$12.00 M$9.60 M
Fixed Assets $1.94 M$1.80 M$1.69 M$1.73 M$1.67 M$1.63 M
Current Assets $10.50 M$10.20 M$7.43 M$12.01 M$27.91 M$30.21 M
Total Assets $12.47 M$13.47 M$10.52 M$15.07 M$30.86 M$33.07 M

Cingulate Inc. Common Stock Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$3.85 M-$4.98 M-$7.59 M-$6.27 M-$9.31 M-$5.87 M
Operating Cash Flow -$4.61 M-$4.80 M-$4.24 M-$3.60 M-$6.91 M-$5.90 M
Investing Cash Flow $0-$5.92 K$0-$156.21 K-$61.18 K-$67.08 K
Financing Cash Flow $1.92 M$4.18 M$1.46 M$8.59 M$21.91 M$8.48 M
Change in Cash -$2.69 M-$618.78 K-$2.78 M$4.83 M$14.94 M$2.51 M

Cingulate Inc. Common Stock Return Calculator

The Cingulate Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
Invest in USA Stock Today

About Cingulate Inc. Common Stock

Cingulate Inc is a clinical-stage biopharmaceutical company focused on the development of products utilizing its drug delivery platform technology that enables the formulation and manufacture of once-daily tablets of multi-dose therapies, with an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety. The Company is developing two proprietary, first-line stimulant medications, CTx-1301 (dexmethylphenidate) and CTx-1302 (dextroamphetamine), for the treatment of ADHD intended for all patient segments: children, adolescents, and adults. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

FAQs

Cingulate Inc. Common Stock (CING) share price as of September 18, 2026 is $5.13. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Cingulate Inc. Common Stock (CING) Share by opening an international trading account with Angel One.
Purchasing Cingulate Inc. Common Stock (CING) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Cingulate Inc. Common Stock (CING) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Cingulate Inc. Common Stock (CING) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Cingulate Inc. Common Stock on September 18, 2026, is $74.02 M.
Cingulate Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Cingulate Inc. Common Stock (CING) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91